Last reviewed · How we verify
Fluconazole 150 mg
Fluconazole 150 mg is a Small molecule drug developed by University of Manitoba. It is currently FDA-approved. Also known as: Diflucan, placebo.
Fluconazole 150 mg is a small molecule inhibitor of the cytochrome P450 51 enzyme, specifically targeting lanosterol 14-alpha demethylase. It is used to treat various fungal infections, including vulvovaginal candidiasis, fungal retinitis, and yeast infections, as indicated by clinical trials on ClinicalTrials.gov.
At a glance
| Generic name | Fluconazole 150 mg |
|---|---|
| Also known as | Diflucan, placebo |
| Sponsor | University of Manitoba |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation (PHASE1, PHASE2)
- A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation (PHASE2)
- The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting (NA)
- Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis (PHASE4)
- Study of Biomarker-Based Treatment of Acute Myeloid Leukemia (PHASE1, PHASE2)
- PTX3-targeted Antifungal Prophylaxis (NA)
- Endothelial Derived Hyperpolarization Factor and Vascular Control (PHASE4)
- Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fluconazole 150 mg CI brief — competitive landscape report
- Fluconazole 150 mg updates RSS · CI watch RSS
- University of Manitoba portfolio CI
Frequently asked questions about Fluconazole 150 mg
What is Fluconazole 150 mg?
Who makes Fluconazole 150 mg?
Is Fluconazole 150 mg also known as anything else?
What development phase is Fluconazole 150 mg in?
Related
- Manufacturer: University of Manitoba — full pipeline
- Also known as: Diflucan, placebo
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing